Diabetes Mellitus as a Cause of Osteoporosis: A Systematic Review
Main Article Content
Abstract
Introduction: Osteoporosis is a metabolic bone condition characterized by decreased bone mineral density and deterioration of the microarchitecture of bone tissue, resulting in fragile bones susceptible to fractures. Diabetes mellitus (DM) is a chronic metabolic disease characterized by persistent hyperglycemia resulting from defects in insulin secretion or action.
Objective: To systematize and analyze the available evidence on the relationship between diabetes mellitus and osteoporosis, exploring the biological mechanisms, clinical impacts and possible management strategies.
Methods: This study constitutes a systematic review, classified as exploratory and descriptive. The research was developed through bibliographic research in electronic databases on methods associated with SLR (Systematic Literature Review) and SMARTER (Simple Multi-Attribute Rating Technique using Exploiting Rankings) applications.
Results: A comprehensive systematic search of the literature yielded a total of 4.490 articles on diabetes mellitus as a cause of osteoporosis, of which 36 articles were eligible to be included in this systematic review.
Conclusion: The challenges observed in the research, such as the difficulty in establishing causal relationships and the presence of confounding factors, indicate the need for more robust and diversified studies. Randomized clinical trials and longitudinal studies will be essential to better understand the relationship between diabetes and osteoporosis, especially with regard to the applicability of therapeutic interventions in different populations.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. ADEJUYIGBE, B.; KALLINI, J.; CHIOU, D.; KALLINI, JR Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. International Journal of Molecular Sciences , vol. 24, no. 19, p. 14583, 26 September. 2023.
II. ÁLVAREZ-MERCADO, AI; MESA, MD; GIL, Á. Vitamin D: Role in chronic and acute diseases. In: Encyclopedia of Human Nutrition . [sl] Elsevier, 2023. p. 535–544.
III. BAILEY, CJ Future Drug Treatments for Type 2 Diabetes. In: Textbook of Diabetes . [sl: sn]. p. 1154–1166.
IV. CAVATI, G.; PIRROTTA, F.; MERLOTTI, D.; CECCARELLI, E.; CALABRESE, M.; GENNARI, L.; MINGIANO, C. Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification. Antioxidants , vol. 12, no. 4, p. 928, 14 April. 2023.
V. CHEN, W.; MAO, M.; FANG, J.; Xie, Y.; RUI, Y. Fracture risk assessment in diabetes mellitus. Frontiers in Endocrinology , vol. 13, 2 Sep. 2022a.
VI. CHEN, Y.; ZHOU, Y.; LIN, J.; ZHANG, S. Challenges to Improve Bone Healing Under Diabetic Conditions. Frontiers in Endocrinology , vol. 13, 28 Mar. 2022b.
VII. DE CANDIA, P.; PRATTICHIZZO, F.; GARAVELLI, S.; DE ROSA, V.; GALGANI, M.; DI RELLA, F.; SPAGNUOLO, MI; COLAMATTEO, A.; FUSCO, C.; MICILLO, T.; BRUZZANITI, S.; CERIELLO, A.; PUCA, AA; MATARESE, G. Type 2 Diabetes: How Much of an Autoimmune Disease? Frontiers in Endocrinology , vol. 10, 4 Jul. 2019.
VIII. FORNER, P.; SHEU, A. Bone Health in Patients With Type 2 Diabetes. Journal of the Endocrine Society , vol. 8, no. 7, 23 May 2024.
IX. GOLDNEY, J.; SARGEANT, JA; DAVIES, MJ Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy. Diabetologia , v. 66, no. 10, p. 1832–1845, 19 Oct. 2023.
X. HOFBAUER, L. C.; BUSSE, B.; EASTELL, R.; FERRARI, S.; FROST, M.; MÜLLER, R.; BURDEN, AM; RIVADENEIRA, F.; NAPOLI, N.; RAUNER, M. Bone fragility in diabetes: novel concepts and clinical implications. The Lancet Diabetes & Endocrinology , vol. 10, no. 3, p. 207–220, 2022.
XI. JADHAV, I.; CHAKOLE, S. Effects of Type 1 Diabetes Mellitus on Linear Growth: A Comprehensive Review. Cureus , 17 September. 2023.
XII. KUPAI, K.; KANG, H.L.; PÓSA, A.; CSONKA, Á.; VÁRKONYI, T.; VALKUSZ, Z. Bone Loss in Diabetes Mellitus: Diaporosis. International Journal of Molecular Sciences , vol. 25, no. 13, p. 7269, 2 July. 2024.
XIII. LEUNGSUWAN, DS; CHANDRAN, M. Bone Fragility in Diabetes and its Management: A Narrative Review. Drugs , 2024.
XIV. LI, G.-F.; ZHAO, P.-P.; XIAO, W.-J.; KARASIK, D.; XU, Y.-J.; ZHENG, H.-F. The paradox of bone mineral density and fracture risk in type 2 diabetes. Endocrine , vol. 85, no. 3, p. 1100–1103, 26 June. 2024.
XV. LIN, H.-H.; HSU, H.-Y.; TSAI, M.-C.; HSU, L.-Y.; CHIEN, K.-L.; YEH, T.-L. Association between type 2 diabetes and osteoporosis risk: A representative cohort study in Taiwan. PLOS ONE , v. 16, no. 7, p. e0254451, 13 Jul. 2021.
XVI. LORENTZON, M.; JOHANSSON, H.; HARVEY, NC; LIU, E.; VANDENPUT, L.; MCCLOSKEY, EV; KANIS, JA Osteoporosis and fractures in women: the burden of disease. Climacteric , vol. 25, no. 1, p. 4–10, 2 Jan. 2022.
XVII. LUCIER, J.; DULEBOHN, SC Type 1 Diabetes . Treasure Island: StatPearls Publishing, 2024.
XVIII. MEIER, C.; EASTELL, R.; PIERROZ, DD; LANE, NE; AL-DAGHRI, N.; SUZUKI, A.; NAPOLI, N.; MITHAL, A.; CHAKHTOURA, M.; FULEIHAN, GE-H.; FERRARI, S. Biochemical Markers of Bone Fragility in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism , vol. 108, no. 10, p. e923–e936, 18 Sept. 2023.
XIX. NASSER, MI; KVIST, AV; VESTERGAARD, P.; EASTELL, R.; BURDEN, AM; FROST, M. Sex ‐ and Age Group ‐ Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus. JBMR Plus , vol. 7, no. 11, 27 Nov. 2023.
XX. NELLAIAPPAN, K.; PREETI, K.; KHATRI, D.K.; SINGH, SB Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies. Current Diabetes Reviews , vol. 18, no. 1, Jan. 2022.
XXI. OJO, OA; IBRAHIM, HS; ROTIMI, DE; OGUNLAKIN, AD; OJO, AB Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology. Medicine in Novel Technology and Devices , vol. 19, p. 100247, Sep. 2023.
XXII. PRASAD, TN; ARJUNAN, D.; PAL, R.; BHADADA, SK Diabetes and Osteoporosis. Indian Journal of Orthopedics , vol. 57, no. S1, p. 209–217, 12 Dec. 2023.
XXIII. PRASATHKUMAR, M.; BECKY, R.; ANISHA, S.; DHRISYA, C.; SADHASIVAM, S. Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight into molecular approaches. Biotechnology Letters , vol. 44, no. 2, p. 203–238, 4 Feb. 2022.
XXIV. RASMUSSEN, NH; DRIESSEN, JHM; KVIST, AV; SOUVEREIN, PC; VAN DEN BERGH, J.; VESTERGAARD, P. Fracture patterns in adult onset type 1 diabetes and associated risk factors – A nationwide cohort study. Bone , vol. 179, p. 116977, Feb. 2024.
XXV. RASMUSSEN, NH; VESTERGAARD, P. Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern? Best Practice & Research Clinical Rheumatology , vol. 36, no. 3, p. 101779, Sep. 2022.
XXVI. SCARPA, E.-S.; ANTONELLI, A.; BALERCIA, G.; SABATELLI, S.; MAGGI, F.; CAPRIOLI, G.; GIACCHETTI, G.; MICUCCI, M. Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis. Biomolecules , vol. 14, no. 7, p. 836, 11 July. 2024.
XXVII. SCHWARTZ, A. V; BACKLUND, J.-YC; DE BOER, IH; RUBIN, MR; BARNIE, A.; FARRELL, K.; TRAPANI, VR; GREGORY, NS; WALLIA, A.; BEBU, I. Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study. The Lancet Diabetes & Endocrinology , vol. 10, no. 7, p. 509–518, 2022.
XXVIII. SHEU, A.; GREENFIELD, JR; WHITE, CP; CENTER, JR Contributors to impaired bone health in type 2 diabetes. Trends in Endocrinology & Metabolism , vol. 34, no. 1, p. 34–48, 2023.
XXIX. SHEU, A.; WHITE, CP; CENTER, JR Bone metabolism in diabetes: a clinician's guide to understanding the bone–glucose interplay. Diabetologia , v. 67, no. 8, p. 1493–1506, 18 Aug. 2024.
XXX. SONG, S.; GUO, Y.; Yang, Y.; FU, D. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacology & Therapeutics , vol. 237, p. 108168, Sep. 2022.
XXXI. SU, J.; LUO, Y.; HU, S.; TANG, L.; OUYANG, S. Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents. International Journal of Molecular Sciences , vol. 24, no. 17, p. 13381, 29 Aug. 2023.
XXXII. TANIOS, M.; BRICKMAN, B.; CAGE, E.; ABBAS, K.; SMITH, C.; ATALLAH, M.; BAROI, S.; LECKA-CZERNIK, B. Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature. Current Osteoporosis Reports , vol. 20, no. 5, p. 229–239, 12 Oct. 2022.
XXXIII. TANWAR, P.; NAAGAR, M.; MAITY, MK Relationship between Diabetes Mellitus and Bone Health–A Review. International Research Journal of Pharmacy and Medical Sciences (IRJPMS) , v. 6, no. 2, p. 46–58, 2023.
XXXIV. TERKAWI, MA; MATSUMAE, G.; SHIMIZU, T.; TAKAHASHI, D.; KADOYA, K.; IWASAKI, N. Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives. International Journal of Molecular Sciences , vol. 23, no. 3, p. 1786, 4 Feb. 2022.
XXXV. WAWRZYNIAK, A.; BALAWENDER, K. Structural and Metabolic Changes in Bone. Animals , vol. 12, no. 15, p. 1946, 31 July. 2022.
XXXVI. XIAO, P.-L.; CUI, A.-Y.; HSU, C.-J.; PENG, R.; JIANG, N.; XU, X.-H.; MA, Y.-G.; LIU, D.; LU, H.-D. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporosis International , vol. 33, no. 10, p. 2137–2153, 10 Oct. 2022.